Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 17,702,000 | 13,283,000 | 14,879,000 | 13,512,000 | 13,491,000 |
| Cost of Goods | 5,263,000 | 3,300,000 | 3,379,000 | 7,562,000 | 9,269,000 |
| Gross Profit | 12,439,000 | 9,983,000 | 11,500,000 | 5,950,000 | 4,222,000 |
| Operating Expenses | 7,480,000 | 8,980,000 | 7,398,000 | 11,295,000 | 7,393,000 |
| Operating Income | 4,959,000 | 1,003,000 | 4,102,000 | -5,345,000 | -3,171,000 |
| Other Income | -244,000 | -1,106,000 | -681,000 | 1,216,000 | -181,000 |
| Pre-tax Income | 4,715,000 | -103,000 | 3,421,000 | -4,129,000 | -3,352,000 |
| Income Tax | 234,000 | -134,000 | 293,000 | -795,000 | -964,000 |
| Net Income Continuous | 4,481,000 | 31,000 | 3,128,000 | -3,335,000 | -2,388,000 |
| Net Income Discontinuous | -8,000 | 17,000 | -5,000 | -26,000 | 12,000 |
| Minority Interests | 8,000 | 7,000 | 8,000 | 9,000 | 6,000 |
| Net Income | $4,465,000 | $41,000 | $3,115,000 | $-3,369,000 | $-2,382,000 |
| EPS Basic Total Ops | 0.79 | 0.01 | 0.55 | -0.59 | -0.42 |
| EPS Basic Continuous Ops | 0.79 | 0.01 | 0.55 | -0.59 | -0.42 |
| EPS Diluted Total Ops | 0.78 | 0.01 | 0.55 | -0.59 | -0.42 |
| EPS Diluted Continuous Ops | 0.79 | 0.01 | 0.55 | -0.59 | -0.42 |
| EPS Diluted Before Non-Recurring Items | 1.06 | 0.60 | 0.82 | 0.10 | -0.17 |
| EBITDA(a) | $6,714,000 | $2,734,000 | $5,838,000 | $-3,675,000 | $-1,611,000 |